Issue 69 - August, 2018
flexReceipts Recognized as Facebook Marketing Partner
flexReceipts, Inc. , a leading innovator of smart, dynamic digital receipts for major retail brands, announced its official status as a Facebook Marketing Partner with the Advanced Onboarding badge for enabling Facebook Offline Conversion insights. The new feature facilitates the real-time, secure transfer of retailers’ in-store transaction data to Facebook, which is then matched with consumers to draw a connection between online advertising activity and in-store purchases. The new insights unlocked by flexReceipts present brands with in-store, offline attribution for their advertising, providing important visibility into how their Facebook ads are affecting in-store sales, and allowing brands to create new lookalike audiences. More information may be viewed here.
KynderMed Taps Marc Lawrence as New Chief Executive Officer
KynderMed, Inc., a medical device company with proprietary technology regulating uterine contractions in pregnant women has named a new CEO. The Company’s Board of Directors has appointed Marc Lawrence, a proven senior executive with extensive experience in developing and accelerating profitable growth for Medical Device/Technology businesses to the position. Marc’s background includes senior executive experiences at Johnson & Johnson, Philips Healthcare and HeartSine Technologies/Stryker, and his vast investor relations and global business development experience promises to deliver value to customers our shareholders. More information may be viewed here.
Vigilant BioSciences Names William Brody as New Chief Executive Officer
Vigilant Biosciences, Inc., an innovator and developer of solutions that aid in the early detection and intervention of oral and throat cancer, announced the appointment of William “Bill” Brodie as CEO.
Bill brings over 20 years of experience in sales and management roles, having previously served as Chief Commercial Officer of Vital Connect, a leader in wearable biosensor technology for wireless hospital and remote patient monitoring. He earlier served as Global Vice President of Sales and Marketing at myoscience where he built and led all commercial operations. Bill also served as Vice President of Global Sales at Solta Medical. From 1998 to 2006, Bill served as Vice President of Sales and Field Operations and held various sales management positions with Benco Dental, a $400 million company specializing in dental office equipment sales, office design and supply management. More information may be viewed here.
Myolyn Featured as Best in Class for Adaptive Fitness Equipment
Myolyn, a provider of proprietary functional electronic stimulation techniques that improve patient outcomes and mobility for those living with a neurological disorder, was recently ranked as a leader in best adaptive fitness equipment sector by Devon Palermo LPTA, CPT, an Adaptive Fitness Specialist, Owner of DPI Adaptive Fitness, and Author of DisAbility Fitness. He noted that the company’s MyoCycle, which they use in their gym, is an excellent way to help manage muscle atrophy through consistent activity, while providing additional benefit such as: a) relaxation of muscle spasms; b) increased local blood circulation; and c) increased range of motion. More information may be viewed here.
Institute Acknowledges Leadership Council Members
The Institute wishes to thank the following members of its Leadership Council for their longstanding support and commitment to the organization and the companies it supports:
Platinum Gold Silver
TRCG Advisors/Alvarez & Marsal Domi Station SunTrust Bank
The Leadership Council is comprised of leading corporations, foundations, and service provider organizations who share the Institute’s vision for a vibrant diversified economy in Florida. Consider supporting the growth of Florida’s innovation ecosystem and join today to help shape Florida’s future! More information may be viewed here.
Don’t Miss the 2018 BioFlorida Annual Conference, October 14-16
Registration is now open for Florida’s premier event for the life sciences community. The 2018 BioFlorida Conference is taking place October 14-16, 2018 at the Westin Fort Lauderdale Beach Resort. Additionally, seed and early stage life science companies will compete in the BioPitch sessions where selected companies will receive mentoring to perfect their pitch and present to life science investors in closed-door sessions at the Conference. Hear from life science executives and industry thought leaders and connect with hundreds of professionals in your field. Meet potential investors and discuss your business plans and financing needs. More information may be viewed here.
Save the Date for the SEBIO Conference, November 13-14
The Southeast BIO (SEBIO) Investor & Partnering Forum will be held November 13-14, 2018 at the Loews Hotel in Atlanta, GA. The conference provides opportunities to meet key decision makers in the regional and national life science and medical technology communities, connecting emerging companies with potential investors and corporate partners. Celebrating its 20th anniversary, SEBIO returns to Atlanta on November 13-14, 2018 with a new format, new networking opportunities, and new investment prospects. More than 300 biotech and medtech investors, corporate executives, university representatives, and entrepreneurs will attend the event this year. More information may be viewed here.
Registration Open for Florida Venture Forum Annual Conference
In celebration of the Florida Venture Forum's 35th Anniversary, the 28th annual conference will be held at the Vinoy Renaissance Resort in St. Petersburg, Florida on January 31 – February 1, 2019. The Annual Florida Venture Capital Conference™ is Florida’s most prominent, “Go To”, capital investment-centric event and gathering each year.
The 2019 Florida Venture Capital Conference offers numerous networking opportunities, programming featuring top investors and deal makers active in the state, and showcases Florida’s most innovative and fast growing later stage, private companies before an audience of venture capitalists, investors, and other service providers. More information may be viewed here.
Formed by the Florida Legislature in 2007, the Institute for Commercialization of Florida Technology a non-profit organization that works collaboratively with the technology licensing and commercialization offices of Florida’s state universities and private research institutions to leverage a $2.5B+ research base and form investable companies that create clean jobs in new industries that are driving the global economy. The Institute provides company building services, and seed funding through the Florida Technology Seed Capital Fund, to promising Florida startups. Seventy-two companies have been funded to date, and the Institute’s economic impact through June 30, 2017 was $970 million, with an annual return on investment of 26 times to the State of Florida.